Breaking News Bar

Business News and Information

FDA approves Cambridge biotech's first-ever drug for cancer

Cambridge biotech Blueprint Medicines Corp. has graduated from a clinical-stage startup to a commercial company.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear